Expert Perspectives on Advances in the Management of C. difficile - Episode 13
C. Difficile Treatment: Bezlotoxumab
The rationale for using bezlotoxumab as treatment for certain patients with C. difficile infections and current limitations that are impacting its use in clinical practice.
Latest News
CDC Director Endorses ACIP Recommendation for Moderna COVID-19 Vaccine for Children and Adolescents
“Long COVID” Caused by High Levels of Virus-Specific T Cells
“Doing Quality Work, With Rigor”: Designing the Next Generation Pneumococcal Vaccine
CDC Identifies Adenovirus Infections in 45% of Acute Hepatitis Cases in Children